Previous Article | Next Article 
Journal of Bacteriology, October 2000, p. 5807-5812, Vol. 182, No. 20
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Characterization of Bacteriophage Lambda
Excisionase Mutants Defective in DNA Binding
Eun Hee
Cho,1
Renato
Alcaraz Jr.,2
Richard I.
Gumport,3 and
Jeffrey
F.
Gardner2,*
Department of Science Education, Chosun
University, Kwangju, Korea,1 and
Department of Microbiology2 and
Department of Biochemistry and College of
Medicine,3 University of Illinois, Urbana,
Illinois
Received 22 May 2000/Accepted 28 July 2000
 |
ABSTRACT |
The bacteriophage
excisionase (Xis) is a sequence-specific DNA
binding protein required for excisive recombination. Xis binds
cooperatively to two DNA sites arranged as direct repeats on the phage
DNA. Efficient excision is achieved through a cooperative interaction
between Xis and the host-encoded factor for inversion stimulation as
well as a cooperative interaction between Xis and integrase. The
secondary structure of the Xis protein was predicted to contain a
typical amphipathic helix that spans residues 18 to 28. Several
mutants, defective in promoting excision in vivo, were isolated with
mutations at positions encoding polar amino acids in the putative helix
(T. E. Numrych, R. I. Gumport, and J. F. Gardner, EMBO
J. 11:3797-3806, 1992). We substituted alanines for the polar amino
acids in this region. Mutant proteins with substitutions for polar
amino acids in the amino-terminal region of the putative helix
exhibited decreased excision in vivo and were defective in DNA binding.
In addition, an alanine substitution at glutamic acid 40 also resulted
in altered DNA binding. This indicates that the hydrophilic face of the
-helix and the region containing glutamic acid 40 may form the DNA
binding surfaces of the Xis protein.
 |
INTRODUCTION |
Site-specific recombination by
bacteriophage
is a complex process that requires the formation of
nucleoprotein complexes composed of specific DNA sites in the phage and
bacterial chromosomes and host- and phage-encoded proteins. Integrative
recombination between specific attachment sites, attP on the
phage DNA and attB on the bacterial chromosome, generates
recombinant attR and attL sites flanking the
prophage DNA (14). Excision of the prophage is accomplished
by site-specific recombination between the attR and
attL sites to regenerate the intact host and phage genomes. Both reactions are catalyzed by the phage-encoded protein integrase (Int), assisted by accessory proteins. The host-encoded integration host factor (IHF) is a protein required for both reactions. Excision requires an additional phage-encoded protein called excisionase (Xis).
Excision is stimulated by the factor for inversion stimulation (FIS)
supplied by the host. The directionality of recombination is determined
by the amount of Xis present in the cell. During prophage induction,
enough active Xis is present to promote excision (7, 26).
The amount of Xis protein present during establishment of lysogeny is
limited due to instability of the protein (26). The
integration reaction is inhibited by Xis in vitro (1, 17).
Xis is a sequence-specific DNA binding protein of 72 amino acids
(1). Xis recognizes two direct, imperfect 13-bp repeats, designated X1 and X2, on the attR site (see Fig. 1)
(28). The FIS binding site, designated F, partly overlaps
the X2 site (24, 25). Xis binds DNA cooperatively at the X1
and X2 sites (4) and also binds to X1 cooperatively with FIS
at the F site (19, 24). Both Xis and FIS bend DNA upon
binding to their specific sites (23). In addition,
occupation of X1 by Xis facilitates binding of Int to the P2 site that
lies adjacent to the X1 site, presumably through protein-protein
interactions (4, 19, 27). The P2 site is a relatively weak
Int binding site and is required for excision but not for integration
(2, 25).
Xis protein is multifunctional despite its small size. It binds to DNA
and interacts with FIS and Int. However, little structural information
on the Xis protein is available. Numrych et al. (19) carried
out an extensive mutational analysis of Xis and isolated amino acid
substitution mutants of Xis with decreased DNA binding affinity in the
bacteriophage P22 challenge-phage assays. Their mutations are located
in the amino-terminal half of the protein. In contrast, other mutations
resulting in defective interaction with Int are at the carboxyl end of
the protein (19, 27). No mutants that bound DNA but failed
to interact with FIS were isolated. Of the 15 amino acid substitution
mutations that decrease DNA binding, 8 change polar residues. Four of
these substitutions are clustered between glutamic acid 19 and arginine
26. In addition, another substitution mutant, E40K, showed decreased
DNA binding in a challenge-phage assay. Because these polar residues
may interact specifically with DNA or FIS, we constructed alanine
substitution mutants of each and analyzed their DNA binding properties
and their ability to promote excision in vivo.
 |
MATERIALS AND METHODS |
Bacterial and phage strains.
Escherichia coli
strain DH5
[supE44
lacU169 (
80
lacZ
M15) hsdR17 recA1 endA1 gyrA96 thi-1
relA1] was used for cloning and purification of variant Xis
proteins. BL21(DE3)[F
ompT
hsdSB(rB
mB
)
gal(
cI857 ind1 Sam7 nin5
lacUV5-T7gene1) dcm] was used for purification of wild-type His-tagged Xis protein. The E. coli strain LE292 {HfrH argE(Am) rpoB
galT::(
[int-FII])} and its fis::kan derivative were used for the
red colony test. LE292 (fis::kan) was
constructed by generalized transduction using phage P1vir grown on E. coli strain MO
(fis::kan) (19). A crude
extract containing the wild-type Xis protein was prepared from RJ1529 (fis::kan) harboring pPS2-3
RS
(19). The challenge phage P22xis2B and its derivatives
containing variant X1-X2-F sites were used as templates for preparation
of DNA in gel-shift assays (see Fig. 1) (18). As a
nonspecific DNA for gel-shift assays, a challenge phage, P22 P'123(II),
was used (15).
Media, chemicals, and enzymes.
The media and buffers were
described previously (19). Antibiotics (Sigma) were added to
the media as follows: ampicillin to 50 µg/ml, spectinomycin to 100 µg/ml, and kanamycin to 50 µg/ml. For the red-colony test, timetin
(SmithKline Beecham Pharmaceuticals) was used instead of ampicillin at
a concentration of 50 µg/ml to prevent the growth of
ampicillin-sensitive satellite colonies. Isopropyl-
-D-thiogalactopyranoside (IPTG) was
obtained from Sigma and used at the indicated concentrations. T4 DNA
ligase, T4 polynucleotide kinase, and restriction endonucleases were
obtained from Bethesda Research Laboratories or New England Biolabs.
Taq DNA polymerase was obtained from Promega.
Plasmid constructions.
PCR was used to isolate and amplify
the xis gene from phage
DNA. The upstream primer Xis-1
contained an NheI restriction site preceding the initiation
codon of the xis gene, and the downstream primer Xis-2
carried an EcoRI site following the xis
translation termination codon (Table 1).
PCR was carried out using Taq DNA polymerase in a solution
containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM
MgCl2, 0.01% gelatin, and 200 µM concentrations of each
deoxynucleoside triphosphate. The fragment was digested with
NheI and EcoRI and ligated into the plasmid
pET28a (Novagen), which was predigested with the same set of enzymes.
After transformation into E. coli strain DH5
, a clone
harboring the insert was confirmed by sequencing (22). The
resulting clone, pYL-XisHP, was transformed into E. coli
BL21(DE3) for expression and purification of the Xis protein.
For excision assays in vivo, the
XbaI-
HindIII
fragment containing the His-tagged
xis gene of the plasmid
pYL-XisHP was subcloned
into the
XbaI-
HindIII
backbone of the plasmid pCKR101 (
15).
The resulting plasmid,
pYL-XisHR, carried the His-tagged
xis gene
under control of
the
Ptac promoter.
Site-directed mutagenesis.
The plasmids containing alanine
substitution mutants, pXisE19A, pXisR22A, pXisR23A, pXisR26A, pXisE27A,
and pXisE40A, were constructed via site-specific mutagenesis using the
modified megaplasmid PCR method (12). Ten picomoles of the
mutagenic oligonucleotide and Xis-2 primer (Table 1) were added to the
template pYL-XisHR DNA. This reaction amplified short fragments
containing desired base-pair changes, which in turn would be used as a
megaprimer in subsequence amplifications. After 10 cycles, 12.5 pmol of
upstream primer, PCKR-p, was added, and DNA was amplified for 10 more
cycles. In the next 10 cycles, 12.5 pmol of Xis-2 was supplied to
finish the amplification. The amplified DNA was digested with
EcoRI and cloned into the EcoRI backbone of the
plasmid pYL-XisHR. Each mutation was confirmed by DNA sequencing.
Expression and purification of His-tagged Xis and its
derivatives.
E. coli strains DH5
, harboring
derivatives of the pYL-XisHR plasmid, and BL21(DE3), with the pYL-XisHP
plasmid, were used for expression of the Xis mutants and the wild-type
Xis protein, respectively. Cells were grown to mid-log phase in
Luria-Bertani medium containing the appropriate antibiotics. Production
of His-tagged proteins was induced by adding IPTG to a final
concentration of 1 mM, followed by growth for 3 h at 37°C. After
centrifugation, harvested cells were disrupted by treatment in a French
pressure cell in 50 mM sodium phosphate buffer, pH 7.4, with 300 mM
NaCl. Prior to disruption, 250 µl of protease inhibitor cocktail for bacterial cell extracts (Sigma product no. P8465) was added per gram of
cell mass. Cell lysates were centrifuged at 12,000 × g for 30 min, and the supernatants were mixed with
nickel-nitrilotriacetic acid column material (Qiagen) saturated in 50 mM sodium phosphate buffer, pH 7.4, with 300 mM NaCl and 10% glycerol.
The column was washed extensively, and the His-tagged proteins were
eluted by adding 250 mM imidazole in the same buffer. The total protein concentrations were measured using the dye-binding assay
(3). The amount of Xis in each protein sample was determined
by measuring peaks after scanning the Coomassie blue-stained sodium
dodecyl sulfate-polyacrylamide gel.
Preparation of crude extracts.
An E. coli strain,
RJ1529, harboring the plasmid pPS2-3
RS (18) was grown at
37°C to mid-exponential phase, and expression of Xis protein was
induced by IPTG at a concentration of 1 mM for 1 h. After
centrifugation, cell pellets were collected and resuspended in a
solution containing 20 mM Tris-HCl (pH 7.4), 100 mM EDTA, 20 mM NaCl,
and 10% glycerol. The cell suspension was sonicated using Branson
Sonifier Cell Disruptor 200 and centrifuged at 20,000 × g for 1 h. The cleared sonic extract was used as a source of
crude Xis protein.
Gel-shift assays.
The DNA fragments used in gel-shift assays
were amplified by PCR using phage P22xis2B or its derivatives as
templates (Fig. 1). The phage P22
P'123(II), which contained the attL Int arm-type binding
sites of
instead of the Xis binding sites, was used as a source of
labeled, nonspecific DNA. A pair of synthetic
oligodeoxyribonucleotides, Omnt and
-Omnt (Table 1), were used as
primers for amplification. They were annealed to the sequences
encompassing the Xis binding sites or Int arm-type binding sites. One
of the primers was labeled with [
-32P]ATP and
polynucleotide kinase prior to amplification (21). The PCRs
were carried out using Taq DNA polymerase (Promega). The DNA
fragments were purified on a Micro Bio-Spin chromatography column 30 (Bio-Rad) and were quantified with a PhosphorImager (Molecular
Dynamics).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 1.
The attR site of bacteriophage and
nucleotide sequences of wild-type and variant Xis binding sites. The
two arm-type binding sites, P1 and P2, and the two core-type sites, C
and B', on the attR region are recognized by Int. IHF binds
to the sites designated as H1 and H2. Xis binds to the X1 and X2 sites.
FIS binds to the F site. The isolation of the mutant Xis binding sites
2B10, 2B29, and 2B22 has been described by Numrych et al.
(18). , deletion of the indicated base.
|
|
Aliquots of labeled DNA fragments were incubated with various
concentrations of Xis proteins in binding buffer (27.5 mM Tris-HCl
[pH
8.0], 33 mM KCl, 25 mM NaCl, 1 mM EDTA, 250 µg of bovine serum
albumin [BSA]/ml, 5% glycerol) at room temperature for 30 min.
Sonicated calf thymus DNA and FIS protein were added to the reaction
as
indicated. The final reaction volumes were adjusted to 10 µl.
After
the entire reaction mixture was loaded and the components
were
separated by electrophoresis in 5% polyacrylamide gels at
room
temperature or at 4°C, the gels were dried and exposed to
X-ray film
for
autoradiography.
Excision assay.
The red-colony test (11) was used
to assay the ability of Xis derivatives to promote excisive
recombination in vivo. The galT gene of E. coli
strain LE292 contains a
prophage that lacks the int and
xis genes. When the Int and Xis proteins are supplied from
plasmids, the inserted prophage is excised from the chromosome and
renders the cells Gal positive. Plasmids containing the wild-type or
mutant xis genes were transformed into strain LE292
containing pIntB1, and the cells were spread on MacConkey
galactose-timetin-spectinomycin plates containing 1 mM IPTG. The plates
were incubated at 30°C, and the time required for the colonies to
turn red was used as a measurement of in vivo excisive recombination activity.
Secondary structure predictions.
The secondary structure of
the Xis protein was predicted using various algorithms available at the
Network Protein Sequence @nalysis web server
(http://www.pbil.ibcp.fr/NPSA). The methods used to analyze the
structure were DPM (5), DSC (13), GOR IV
(9), PHD (20), Predator (8), SIMPA96
(16), and SOPM (10).
 |
RESULTS AND DISCUSSION |
His-tagged Xis retains the binding specificity and functions of
Xis.
In order to simplify the purification of Xis and its mutant
derivatives, we constructed a modified gene that encoded a His tag at
the amino terminus of the protein. The xis gene from phage
was amplified and cloned into the NheI-EcoRI
backbone of plasmid pET28a as described in Materials and Methods. The
resulting clone, pYL-XisHP, was transformed into E. coli
BL21(DE3) for expression and subsequent purification of the His-tagged
Xis. After isolating the wild-type His-tagged protein, we analyzed its
sequence-specific DNA binding properties in vitro by gel-shift assays.
The DNA fragments used in the binding reactions contained either the
wild-type X1-X2-F sites or the variant sites shown in Fig. 1. The
mutant site 2B10 carries a 4-bp deletion in the X2 site. The other two
variant sites, 2B29 and 2B22, have a single-nucleotide substitution in X1 and X2, respectively. Variants were isolated as mutants defective for Xis binding using the challenge-phage system (18).
The purified wild-type His-tagged Xis bound DNA containing the
wild-type X1-X2-F sites (Fig.
2A, lanes 2 and
3). Addition
of FIS to the reaction
facilitated binding of His-tagged Xis to
its binding site, indicating
that His-tagged Xis interacts cooperatively
with FIS in DNA binding
(Fig.
2A, lanes 5 and 6). Similar results
showing weak cooperativity
between FIS and Xis have been reported
previously (
19,
25).
The Xis protein did not bind the deletion
variant site 2B10, but FIS
protein shifted DNA fragments containing
the variant 2B10 (Fig.
2A,
lanes 7 to 12). The mutant site 2B29
was bound by His-tagged Xis but
with lower affinity than the wild-type
site (Fig.
2A, lanes 13 to 18).
Mutant 2B22 was bound only when
FIS was present (Fig.
2A, lanes 19 to
24).

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 2.
DNA binding specificity of His-tagged Xis (A) and the
wild-type Xis (B). The 32P-labeled DNA fragments were about
180 bp long and were amplified from P22 challenge phages containing
either wild-type or variant Xis binding sites. A 1X amount of Xis (A)
corresponds to 0.1 µM protein. The wild-type Xis protein (B) was in
crude extracts prepared from an E. coli strain, RJ1529,
containing the plasmid pPS2-3 RS (18). Each reaction
contained 2.5 nM labeled DNA, and where indicated, 12.5 ng (A) or 7.6 ng (B) of FIS was present. As a nonspecific competitor, 0.25 µg (A)
or 1 µg (B) of sonicated calf thymus DNA was added. Electrophoresis
was performed at room temperature. A contaminating fragment (probably
single-stranded DNA) occurring as an artifact of the PCR migrated
between the Xis-DNA complex and the FIS-DNA complex.
|
|
The binding patterns of the fusion protein were the same as those of
the wild-type Xis protein without the His tag (Fig.
2B),
showing that
the positively charged His tag was not affecting
binding. When crude
extracts containing the wild-type Xis protein
were added to DNA with
Xis binding sites, Xis-DNA complexes were
detected only with the
wild-type binding site, not with the mutant
binding sites 2B29 and 2B22
(Fig.
2B, lanes 1, 4, and 7). If FIS
protein was supplied to the
reaction, Xis-FIS-DNA complexes were
detected in the reactions with all
three Xis binding sequences.
However, the amounts of the ternary
complexes formed with the
variant sites, 2B29 and 2B22, were
significantly less than with
wild-type DNA (Fig.
2B, lanes 3, 6, and
9). Thus, the His-tagged
Xis protein binds specifically to its binding
sites and interacts
cooperatively with the FIS
protein.
To measure the recombination activity of the protein in vivo, DNA
encoding the His-tagged
xis gene was subcloned downstream
of
the
Ptac promoter as described in Materials and
Methods. The
resultant plasmid, pYL-XisHR, was transformed into LE292
containing
the Int-producing plasmid pIntB1 (
19). Excision
was assayed
by the red-colony test (
11). The Xis protein
produced from the
plasmid pYL-XisHR functioned as efficiently as the
wild-type Xis
protein without the His tag in the excision reaction.
Colonies
turned red within 24 h on MacConkey-galactose plates
containing
1 mM IPTG. It took another 12 h if the host carried a
defective
fis gene. Taken together with the gel-shift data,
this led us
to conclude that the His tag does not significantly affect
the
functions of Xis protein, including DNA binding and cooperative
interactions with FIS. All the following data were obtained using
His-tagged versions of
Xis.
Amino acid residues from Leu 18 to Glu 27 may form an amphipathic
-helix.
The carboxyl-terminal region of Xis is required for
cooperative binding of Int, presumably through protein-protein
interactions (19, 27). A nonsense mutant was isolated that
encodes an Xis protein containing the amino-terminal 53 amino acids. It
bound to DNA containing the X1-X2-F sites and interacted cooperatively with the FIS protein (19). The precise regions of Xis
involved in DNA binding or FIS interaction were not localized.
Secondary structure prediction algorithms indicated that three regions
of the Xis protein could form
-helices (5, 8, 9, 10, 13, 16,
20). Amino acids from residues 5 to 10 were predicted to form the
first helix, and the region spanning leucine 18 to glutamic acid 27 was
predicted to form the second helix. The third postulated helix was in
the region proposed by Numrych et al. (19) to be involved in
cooperative interactions with Int. However, Xis lacked recognizable DNA
binding motifs, for example, a helix-turn-helix motif (6).
We observed that although Xis does not form a canonical helix-turn-helix motif, the second helical region could form a typical
amphipathic helix (Fig. 3). Furthermore,
Numrych et al. (19) found that several substitutions for the
hydrophilic residues in this region resulted in a loss of Xis function
in vivo. Those substitutions included the changing of glutamic acid 19 to a lysine, arginine 22 to a histidine, arginine 23 to a glutamine,
and arginine 26 to a tryptophan. Those results are consistent with the
hypothesis that this region forms an
-helix and the surface-exposed
hydrophilic residues may be in direct contact with DNA or FIS.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 3.
Helical wheel projection of the putative -helix
spanning amino acid residues 18 to 27 in Xis. The residues named in the
boxes are the amino acids for which substitutions resulted in defective
excision in vivo (19).
|
|
Substitutions for polar residues in the putative amphipathic helix
change DNA binding.
To gain more information on the function of
each of the polar side chains on the putative amphipathic helix, we
constructed alanine substitution mutants of the hydrophilic residues.
Glutamic acid 19, arginines 23 and 26, and glutamic acid 27 were
individually replaced with an alanine residue. The proteins were
designated E19A, R23A, R26A, and E27A, respectively. We also
constructed a mutant with an alanine substitution at position 22, but
we could not detect the protein on a sodium dodecyl
sulfate-polyacrylamide gel. This mutant was not analyzed further. Each
of the Xis variants was tested for DNA binding and ability to promote
excision in vivo. Gel-shift assays were performed using partially
purified proteins as described in Materials and Methods.
The mutant E27A protein bound DNA containing the X1-X2-F sites with an
affinity similar to that of the wild-type protein.
It also
discriminated between the wild-type and variant Xis binding
sites as
did the wild-type protein (data not shown). Variants
R23A and R26A,
however, failed to form specific complexes with
DNA in the absence of
the FIS protein, even when 50-fold more
protein was added to the
reactions than in reactions using the
wild-type Xis. Mutants R23A and
R26A formed a complex with DNA
containing wild-type Xis binding sites
only in the presence of
FIS (Fig.
4A).
However, they failed to bind the variant site 2B10
under the same
conditions (Fig.
4B). These results indicate that
although the latter
two mutants have decreased DNA binding affinity,
they retain the
ability to interact with the FIS protein. They
bind to the specific Xis
binding site only when FIS is present.

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 4.
DNA binding of XisR23A and XisR26A. The final
concentration of wild-type Xis was 0.1 µM, and that of the mutant Xis
proteins was 5 µM. Each reaction contained 2.5 nM labeled DNA and 50 ng of sonicated calf thymus DNA. Where indicated, 6.3 ng of FIS was
present. Electrophoresis was performed at 4°C.
|
|
Another variant, E19A, bound DNA differently. The E19A protein did not
form a discrete complex with DNA containing the X1-X2-F
sites as the
wild-type protein did. Instead, it formed complexes
that migrated
slowly only at high protein concentrations (Fig.
5B, lane
1). Multiple, discrete complexes were
formed when the
protein was present at lower concentrations (Fig.
5B,
lanes 2
and 3). We suggest that the rapidly migrating bands are
complexes
with the mutant protein bound nonspecifically to DNA. To test
if the E19A protein could bind to a sequence lacking the Xis or
FIS
binding sites, we used DNA containing the P'1-P'2-P'3 Int
arm-type
binding sites of

. As shown in Fig.
5B, lanes 4 to 6,
the E19A
protein also formed multiple discrete complexes with
nonspecific DNA.
We interpret the multiple bands to be nonspecific
complexes with
various amounts of the Xis E19A protein bound to
a single DNA fragment.
We note that the binding affinity of E19A
for nonspecific DNA was
greater than that of the wild-type Xis
(Fig.
5). At a 31 nM
concentration, wild-type Xis formed neither
specific nor nonspecific
complexes (Fig.
5A, lanes 3 and 7). Specific
complexes of the wild-type
Xis with DNA fragments containing the
Xis binding site were detected
when 125 nM protein or more was
added (Fig.
5A, lanes 1 and 2). Under
the same conditions (125
and 500 nM Xis), small amounts of nonspecific
complexes were also
detected (Fig.
5A, lanes 1, 2, 5, and 6). In
contrast, the E19A
protein bound nonspecifically to DNA at a
concentration of 31
nM (Fig.
5B, lanes 3 and 7).

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 5.
DNA binding patterns of wild-type Xis (A), XisE19A (B),
and XisE40A (C). The specific DNA fragments contained the Xis and FIS
binding sites, X1-X2-F. The band indicated by an arrow in panel A
corresponds to a specific Xis-DNA complex. Nonspecific DNA contained
the Int arm-type sites P'1, P'2, and P'3 in place of the Xis and FIS
binding sites. The flanking sequences of nonspecific DNA were the same
as those of the specific DNA fragment. The final concentration of
labeled DNA in each reaction was 1 nM. Nonspecific competitor DNAs were
absent from the reactions. Electrophoresis was performed at room
temperature. A contaminating fragment migrating slower than free DNA is
believed to be single-stranded because it was not retarded by the
nonspecific DNA binding mutants.
|
|
The ability of each mutant to promote the excision reaction of

in
vivo was assessed by the red-colony test. The results
are shown in
Table
2. The E27A protein promoted
excision as efficiently
as the wild-type protein when expression of
proteins was induced
by IPTG at a concentration of 1 mM. Two variants,
R23A and R26A,
could excise

DNA only in the presence of FIS but not
as well
as the wild type did. These results are consistent with the
gel-shift
data. It was surprising to find that the E19A protein also
promoted
excision, albeit with lower efficiency than the wild-type Xis.
One explanation for this result is that although the E19A protein
binds
to nonspecific DNA significantly better than the wild-type
Xis, it
might continue to form a bent DNA complex when bound to
the specific
site, thereby stimulating excision. The fact that
the E19A protein
promotes excision better in the presence of the
FIS protein also
indicates that it interacts cooperatively with
the FIS protein. Thus,
with help of FIS, the E19A protein may
be effectively recruited to the
Xis binding site to bend DNA and
to promote the excision reaction.
Mutant with a substitution of an alanine for glutamic acid 40 binds
to nonspecific DNA.
Numrych et al. (19) also isolated a
mutant in which glutamic acid 40 was replaced by a lysine. To study the
function of this residue in DNA recognition in more detail, we made a
His-tagged construct of it. Gel-shift assays showed that the E40A
protein, like the E19A protein, bound to both specific and nonspecific DNA fragments (Fig. 5C, lanes 5 to 8). However, the binding pattern for
the fragment with specific sequences was different from that for the
fragment with nonspecific DNA sequences (Fig. 5C). Although we do not
understand the cause of the difference, it might indicate that the E40A
protein distinguishes the specific Xis binding sites from random DNA to
some extent. The fact that the E40A mutant promoted excision and showed
cooperativity with FIS (Table 2) supports this hypothesis. As discussed
above for the E19A protein, the E40A protein may also bend DNA when
bound to a specific Xis binding site and provides a functional
substrate for excision. However, the sequence specificity of the
wild-type Xis was significantly relaxed by the substitution for
glutamic acid 40, indicating that this residue may also participate,
either directly or indirectly, in sequence-specific DNA recognition.
In summary, we constructed mutant Xis proteins with alanine
substitutions of polar residues on the putative amphipathic

-helix
and glutamic acid 40. Three of the four alanine substitutions,
E19A,
R23A, and R26A, altered the DNA binding patterns of Xis.
One
substitution, E27A, which resulted in a change at the carboxyl
end of
the helix, did not change the DNA binding specificity of
Xis. This
behavior is consistent with the hypothesis that Xis
forms an
amphipathic

-helix from leucine 18 to glutamic acid
27, although the
latter amino acid residue may not interact with
DNA. This study
suggests that the amino-terminal, hydrophilic
face of the amphiphatic
helix may be in close contact with DNA.
In particular, glutamic acid 19 appears to play a role, direct
or indirect, in conferring DNA binding
specificity, and arginines
at positions 23 and 26 are required to bind
to DNA with high affinity.
The finding that a substitution for glutamic
acid 40 also increased
binding affinity to nonspecific DNA suggests
that the region containing
glutamic acid 40 may form an additional DNA
binding surface on
the Xis
protein.
We note that the putative helical region from amino acid 18 to 28 and
the region carrying glutamic acid 40 are separated by
an unusual amino
acid sequence containing three consecutive prolines.
Thus, the proline
residues may play a role in positioning the
flanking amino acid
residues in a conformation that allows them
to interact simultaneously
with DNA. We look forward to comparing
our analysis to the emerging
structural studies. The combination
of the two approaches may reveal
the exact nature of the functional
interactions between the amino acids
and binding-site DNA that
lead to
excision.
 |
ACKNOWLEDGMENTS |
We thank R. Johnson for providing the purified FIS protein and
strain RJ1529 and Yu-Hong Li for constructing plasmids pYL-XisHP and
pYL-XisHR. We also thank R. Johnson and H. Huang for constructive comments on the manuscript.
This work was supported by NIH grant 28717 and KOSEF grant
971-0502-009-2 from the Korea Science and Engineering Foundation.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: B103 Chemical
and Life Science Lab., 601 S. Goodwin Ave., Urbana, IL 61801. Phone: (217) 333-7287. Fax: (217) 244-6697. E-mail:
jeffgard{at}uiuc.edu.
 |
REFERENCES |
| 1.
|
Abremski, K., and S. Gottesman.
1982.
Purification of the bacteriophage xis gene product required for excisive recombination.
J. Biol. Chem.
257:9658-9662[Abstract/Free Full Text].
|
| 2.
|
Bauer, C. E.,
S. D. Hesse,
R. I. Gumport, and J. F. Gardner.
1986.
Mutational analysis of integrase arm-type binding sites of bacteriophage lambda.
J. Mol. Biol.
121:179-192.
|
| 3.
|
Bradford, M. M.
1976.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem.
72:248-253[CrossRef][Medline].
|
| 4.
|
Bushman, W.,
S. Yin,
L. Thio, and A. Landy.
1984.
Determinants of directionality in lambda site-specific recombination.
Cell
39:699-707[CrossRef][Medline].
|
| 5.
|
Deleage, G., and B. Roux.
1987.
An algorithm for protein secondary structure prediction based on class prediction.
Protein Eng.
1:289-294[Abstract/Free Full Text].
|
| 6.
|
Dodd, I. B., and J. B. Egan.
1990.
Improved detection of helix-turn-helix DNA-binding motifs in protein sequences.
Nucleic Acids Res.
18:5019-5026[Abstract/Free Full Text].
|
| 7.
|
Echols, H., and G. Guarneros.
1983.
Control of integration and excision, p. 75-93.
In
R. Hendrix, J. Roberts, F. Stahl, and R. Weisberg (ed.), Lambda II. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 8.
|
Frishman, D., and P. Argos.
1996.
Incorporation of non-local interactions in protein secondary structure prediction from the amino acid sequence.
Protein Eng.
9:133-142[Abstract/Free Full Text].
|
| 9.
|
Garnier, J.,
J. F. Gibrat, and B. Robson.
1996.
GOR method for predicting protein secondary structure from amino acid sequence.
Methods Enzymol.
266:540-553[Medline].
|
| 10.
|
Geourjon, C., and G. Deleage.
1994.
SOPM: a self-optimized method for protein secondary structure prediction.
Protein Eng.
7:157-164[Abstract/Free Full Text].
|
| 11.
|
Han, Y. W.,
R. I. Gumport, and J. F. Gardner.
1994.
Mapping the functional domains of bacteriophage lambda integrase protein.
J. Mol. Biol.
235:908-925[CrossRef][Medline].
|
| 12.
|
Ke, S.-H., and E. L. Madison.
1997.
Rapid and efficient site-directed mutagenesis by single-tube `megaprimer' PCR method.
Nucleic Acids Res.
25:3371-3372[Abstract/Free Full Text].
|
| 13.
|
King, R. D., and M. J. Sternberg.
1996.
Identification and application of the concepts important for accurate and reliable protein secondary structure prediction.
Protein Sci.
5:2298-2310[Medline].
|
| 14.
|
Landy, A.
1989.
Dynamic, structural, and regulatory aspects of site-specific recombination.
Annu. Rev. Biochem.
58:913-950[Medline].
|
| 15.
|
Lee, E. C.,
R. I. Gumport, and J. F. Gardner.
1990.
Genetic analysis of bacteriophage integrase interactions with arm-type attachment site sequences.
J. Bacteriol.
172:1529-1538[Abstract/Free Full Text].
|
| 16.
|
Levin, J. M.,
B. Robson, and J. Garnier.
1986.
An algorithm for secondary structure determination in proteins based on sequence similarity.
FEBS Lett.
205:303-308[CrossRef][Medline].
|
| 17.
|
Nash, H.
1975.
Integrative recombination of bacteriophage lambda DNA in vitro.
Proc. Natl. Acad. Sci. USA
72:1072-1076[Abstract/Free Full Text].
|
| 18.
|
Numrych, T. E.,
R. I. Gumport, and J. F. Gardner.
1991.
A genetic analysis of Xis and FIS interactions with their binding sites in bacteriophage lambda.
J. Bacteriol.
173:5954-5959[Abstract/Free Full Text].
|
| 19.
|
Numrych, T. E.,
R. I. Gumport, and J. F. Gardner.
1992.
Characterization of the bacteriophage lambda excisionase (Xis) protein: the C-terminus is required for Xis-integrase cooperativity but not for DNA binding.
EMBO J.
11:3797-3806[Medline].
|
| 20.
|
Rost, B., and C. Sander.
1993.
Prediction of protein secondary structure at better than 70% accuracy.
J. Mol. Biol.
232:584-599[CrossRef][Medline].
|
| 21.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 22.
|
Sanger, F.,
S. Nicklen, and A. Coulson.
1977.
DNA sequencing with chain- terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467[Abstract/Free Full Text].
|
| 23.
|
Thompson, J. F., and A. Landy.
1988.
Empirical estimation of protein-induced DNA bending angles: applications to site-specific recombination complexes.
Nucleic Acids Res.
16:9687-9705[Abstract/Free Full Text].
|
| 24.
|
Thompson, J. F.,
L. Moitoso de Vargas,
S. E. Skinner, and A. Landy.
1987.
Protein-protein interactions in a higher-order structure direct lambda site-specific recombination.
J. Mol. Biol.
195:481-493[CrossRef][Medline].
|
| 25.
|
Thompson, J. F.,
L. Moitoso de Vargas,
C. Koch,
R. Kahmann, and A. Landy.
1987.
Cellular factors couple recombination with growth phase: characterization of a new component in the site-specific recombination pathway.
Cell
50:901-908[CrossRef][Medline].
|
| 26.
|
Weisberg, R. A., and M. E. Gottesman.
1971.
The stability of Int and Xis functions, p. 489-500.
In
A. D. Hershey (ed.), The bacteriophage lambda. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 27.
|
Wu, Z.,
R. I. Gumport, and J. F. Gardner.
1998.
Defining the structural and functional roles of the carboxyl region of the bacteriophage lambda excisionase (Xis) protein.
J. Mol. Biol.
281:651-661[CrossRef][Medline].
|
| 28.
|
Yin, S.,
W. Bushman, and A. Landy.
1985.
Interaction of the lambda site-specific recombination protein Xis with attachment site DNA.
Proc. Natl. Acad. Sci. USA
82:1040-1044[Abstract/Free Full Text].
|
Journal of Bacteriology, October 2000, p. 5807-5812, Vol. 182, No. 20
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Mattis, A. N., Gumport, R. I., Gardner, J. F.
(2008). Purification and Characterization of Bacteriophage P22 Xis Protein. J. Bacteriol.
190: 5781-5796
[Abstract]
[Full Text]
-
Abbani, M. A., Papagiannis, C. V., Sam, M. D., Cascio, D., Johnson, R. C., Clubb, R. T.
(2007). Structure of the cooperative Xis-DNA complex reveals a micronucleoprotein filament that regulates phage lambda intasome assembly. Proc. Natl. Acad. Sci. USA
104: 2109-2114
[Abstract]
[Full Text]
-
ElAntak, L., Ansaldi, M., Guerlesquin, F., Mejean, V., Morelli, X.
(2005). Structural and Genetic Analyses Reveal a Key Role in Prophage Excision for the TorI Response Regulator Inhibitor. J. Biol. Chem.
280: 36802-36808
[Abstract]
[Full Text]
-
Cho, E. H., Gumport, R. I., Gardner, J. F.
(2002). Interactions between Integrase and Excisionase in the Phage Lambda Excisive Nucleoprotein Complex. J. Bacteriol.
184: 5200-5203
[Abstract]
[Full Text]
-
Lewis, J. A., Hatfull, G. F.
(2001). Control of directionality in integrase-mediated recombination: examination of recombination directionality factors (RDFs) including Xis and Cox proteins. Nucleic Acids Res
29: 2205-2216
[Abstract]
[Full Text]